Xingbing Li

Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway.

Jian Shen, Suxin Luo, Dingyi Lv, 2020, Journal of ethnopharmacology.

NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice.

Yong Xia, Suxin Luo, Dingyi Lv, 2022, Microvascular research.

Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression.

Suxin Luo, Dingyi Lv, Minghao Luo, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Tubeimoside I improves endothelial function in sepsis via activation of SIRT3

Jian Shen, Suxin Luo, Xiang Li, 2021, Laboratory Investigation.

Tubeimoside I protects against sepsis-induced cardiac dysfunction via SIRT3.

Jian Shen, Suxin Luo, Dingyi Lv, 2021, European journal of pharmacology.

Gastrin attenuates sepsis-induced myocardial dysfunction by down-regulation of TLR4 expression in macrophages

Y. Li, Bo-Sheng He, H. Ren, 2023, Acta pharmaceutica Sinica. B.

β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury

Bo-Sheng He, Xiaoli Yang, Xingbing Li, 2023, Molecular Medicine.